[Magnetic resonance neurography in peripheral neuropathy or plexopathy]

Mejia J, Merlott,L, Ciapponi A, Alfie V, Fernandez Ortiz S, Latorraca M, Augustovski F, García Martí S, Bardach A, Alcaraz A, Pichon Riviere A
Record ID 32018013310
Spanish
Original Title: Actualización: Neurografía por resonancia magnética en neuropatía periférica o plexopatía
Authors' recommendations: Very low-quality evidence resulting from observational studies does not allow to draw conclusions about the effectiveness/safety of Magnetic Resonance Neurography in individuals with peripheral neuropathy or plexopathy. No evidence of clinical outcomes such as surgical success, postoperative sequelae, motor and sensory function recovery or adverse events, has been found. The studies show adequate specificity of the Magnetic Resonance Neurography suggesting a potential usefulness in confirming diagnoses, while its sensitivity varies according to the type of neuropathy, nerve involved, location and other factors. Clinical practice guidelines differ in their recommendations. Two of the guidelines consulted recommend routine use of Magnetic Resonance Neurography to diagnose neuropathies; however, they mention that its use might be considered in those cases where diagnosis is difficult, and to diagnose plexopathies. The third guideline recommends the use of neurography in cases of brachial and lumbosacral plexus neuropathies; although the evidence on which they based their recommendations did not contemplate clinical outcomes. In the United States of America, Anthem and Aetna do not mention coverage of this technology, while Cigna provides conditional coverage in patients with diagnostic uncertainty. Health funders from Australia, Canada, France and Latin America, including Argentina, do not mention Magnetic Resonance Neurography in their coverage policies. Since the evidence is of very low quality, the net benefit is considered uncertain and no conclusions about its cost-effectiveness can be drawn. Furthermore, there are no economic studies carried out in Argentina or in the region.
Details
Project Status: Completed
Year Published: 2024
URL for published report: https://ets.iecs.org.ar/publication/2198
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Magnetic Resonance Imaging
  • Brachial Plexus Neuropathies
  • Peripheral Nervous System Diseases
  • Peripheral Nerves
Contact
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: <p>Institute for Clinical Effectiveness and Health Policy (IECS)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.